Management of L-Dopa Overdose in the Competitive Inhibition State [Expression of Concern]
Hinz M, Stein A, Cole T. Drug Healthc Patient Saf. 2014;6:93–99. The Editor-in-Chief and Publisher of Drug, Healthcare and Patient Safety wish to issue an Expression of Concern for the published article. Concerns have been raised regarding the alleged undisclosed...
Main Authors: | Hinz M, Stein A, Cole T |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-04-01
|
Series: | Drug, Healthcare and Patient Safety |
Subjects: | |
Online Access: | https://www.dovepress.com/eoc-management-of-l-dopa-overdose-in-the-competitive-inhibition-s-peer-reviewed-article-DHPS |
Similar Items
-
Management of L-Dopa Overdose in the Competitive Inhibition State [Retraction]
by: Hinz M, et al.
Published: (2020-12-01) -
The Use of the Calcitonin Minimal Recognition Module for the Design of DOPA-Containing Fibrillar Assemblies
by: Galit Fichman, et al.
Published: (2014-08-01) -
The Parkinson’s Disease Death Rate: Carbidopa and Vitamin B6 [Expression of Concern]
by: Hinz M, et al.
Published: (2020-04-01) -
A Novel Method for Creating a Synthetic L-DOPA Proteome and In Vitro Evidence of Incorporation
by: Joel Ricky Steele, et al.
Published: (2021-05-01) -
Amino Acid Management of Parkinson’s Disease: A Case Study [Expression of Concern]
by: Hinz M, et al.
Published: (2020-04-01)